Navigation Links
Merge president steps down in wake of shareholder suits

sure issues facing the company as quickly as possible," Dunham added.

Shareholder unrest

The lawsuits represent people who bought shares of Merge between August 2, 2005, and March 16, 2006. The lawsuits against Merge were filed less than one week after the company acknowledged that it expects to report "material weaknesses" related to its internal controls over financial r......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 05/16/06


Page: 1 2 3

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Merge Technologies net loss doubles to $10.1M
3. Merge unveils next-generation imaging-informatics product
4. Merge unveils updated medical imaging software
5. Merge Healthcare suffers $258M loss in `06
6. Merge Healthcare unveils diagnostic mammography tool
7. Merge Healthcare promotes Bowers to president
8. Merge Healthcare hires new VP of finance
9. Merge offshoring jobs to "more cost-effective" workforce
10. Merge Healthcare reports $10.8M net loss in Q3
11. Merge eMed releases software upgrade

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Merge president steps down wake shareholder suits

(Date:11/19/2009)... Germany, November 19 MONITORING F...er 16th, 2009 Flibanserin in the,indication treatm...son,s,disease for orphan drug status designation w...-induced dyskinesia is a complication of the mains...s burden to some of those,affected, since it may b...
(Date:11/19/2009)...InSound is honored by latest award for revolutiona... CA (PRWEB) November 16, 2009 -- Popular Science M...; hearing aid from InSound Medical a winner of its...lth category.    Chosen from t...deep in the hearing canal for up to four months wh...
(Date:11/18/2009)...eed to be able to find explosive materials and per...ch searches, the National Institute of Standards a...ment of Homeland Security, has developed a new cer...rial (SRM) 2905, Trace Particulate Explosives. Com...he SRM will be helpful in calibrating, testing and...
(Date:11/18/2009)...perience in data analysis combined with Bio-Rad,s ...ts and curricula provide state-of-the-art solution...e., Nov. 18 Vernier Software &...erfaces, sensors, and software and Bio-Rad Laborat...ributor of life science research and clinical diag...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3New NIST trace explosives standard slated for homeland security duty 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
...g and diagnostic discovery company, has completed ...isease test. The company expects to have,this test...LP (Good,Laboratory Practices) compliant laborator...9. This initial ExonHit test aims to identify pat...mple blood sample. Further developments are,underw...
...vations, Inc. (Amex: IMA ), announced today that ... conditions, 7,000,000 shares of its common,stock ...ent in an,underwritten public offering. Certain se...g to sell up to 165,698 shares of common stock in ...erwriters a 30-day option to,purchase up to an add...
...Advocating Use of Hand Cleansers With CHG f...a., Nov. 8 Headlines call MRSA (methicillin-,resi...nd the media continue,to report daily on recent sc...nt deaths due to this drug-resistant staph infecti...of the best means of preventing a,MRSA-related ski...
Other Biology Technology:ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 2ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 3ExonHit Completes a Prototype to Detect Alzheimer's Disease From Blood 4Inverness Medical Innovations Announces Proposed Public Offering of Common Stock 2Inverness Medical Innovations Announces Proposed Public Offering of Common Stock 3Soap and Water May not be Enough to Fight MRSA Superbug 2Soap and Water May not be Enough to Fight MRSA Superbug 3
(Date:11/20/2009)... Research Center (ERC) has been awarded a grant fr...methods of recovering and reusing the heat that wo...pression process in a carbon capture system. The g...n capture and sequestration, or storage (CCS), and... emitted into the atmosphere by coal-fired power p...
(Date:11/19/2009)...ists are revealing the genetic instructions inside... maize, has one of the most complex sequences of D...ison genomicist David Schwartz, who was one of mor...Science . , "The maize genome is a true maze fu...oubled would-be sequencers for years," says Schwar...
(Date:11/19/2009)...ov. 19 BIO-key Internati... wireless public safety and finger-based biometric...ial Shareholder Meeting held today was adjourned w... not present. ,, (Logo: http://www.newscom.com...impressive 99.3% of the 35 million votes cast vote...
Breaking Biology News(10 mins):Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3Sweet corn story begins in UW-Madison lab 2Sweet corn story begins in UW-Madison lab 3BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 1Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 2Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 3Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 4Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 5Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 6Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 7Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 8Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 9Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 10Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 11Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 12Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 13Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 14Novartis drug Tasigna 28R 29 meets primary endpoint in pivotal trial against Gleevec 28R 29 as first line treatment in chronic myeloid leukemia patien 5579 15Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 1Judge Halts IHSS Home Care Cuts 3B Says They Likely Violate Federal Law 59781 2Checkered history of mother and daughter cells explains cell cycle differences 10424 1Checkered history of mother and daughter cells explains cell cycle differences 10424 2Checkered history of mother and daughter cells explains cell cycle differences 10424 3
... marine creatures in the vast, dark deep-sea surro...ming worms, crustaceans, and molluscs living in th...ion of ocean life. , Reporting this week in the jo... the deeper parts of the Southern Ocean - the sour...are likely to be related to animals living in both...
... potentially valuable organisms are at risk from s...de, says a new study led by a University of Toront...hide deposits near "black smokers"—undersea hydrot...ater into the frigid deep-sea environment, and sup...clam species—could smother and contaminate these c...
...and control yellow fever and dengue fever has beco...draft of the genome sequence of Aedes aegypti mosq...nstitute for Genomic Research (TIGR) and David Sev...is the complete set of genetic material including ... The research appears in the May 18, 2007 Science ...
Other Biology News:Scientists discover new life in the Antarctic deep sea 2Study warns deep-sea mining may pose serious threat to fragile marine ecosystems 2Study warns deep-sea mining may pose serious threat to fragile marine ecosystems 3Genome of yellow fever/dengue fever mosquito sequenced 2Genome of yellow fever/dengue fever mosquito sequenced 3
Sheep Anti-Staphylococcus DNase Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-zona radiata Monoclonal Antibody, Unconjugated, Clone MN-8C4 from Abcam
Rabbit Anti-KIAA1276 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Chk1, phospho (Ser296) Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Biology Products: